Lin L - Search Results

1

SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters.

Zhang H, Zheng Z, Zhang R, Yan Y, Peng Y, Ye H, Lin L, Xu J, Li W, Huang P. Zhang H, et al. Among authors: lin l. Cell Death Dis. 2021 Jul 23;12(8):731. doi: 10.1038/s41419-021-04009-8. Cell Death Dis. 2021. PMID: 34301921 Free PMC article.

2

Correction: SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters.

Zhang H, Zheng Z, Zhang R, Yan Y, Peng Y, Ye H, Lin L, Xu J, Li W, Huang P. Zhang H, et al. Among authors: lin l. Cell Death Dis. 2021 Aug 16;12(9):793. doi: 10.1038/s41419-021-04071-2. Cell Death Dis. 2021. PMID: 34400616 Free PMC article. No abstract available.

3

Expression of CCN family members correlates with the clinical features of hepatocellular carcinoma.

Zhang H, Li W, Huang P, Lin L, Ye H, Lin D, Koeffler HP, Wang J, Yin D. Zhang H, et al. Among authors: lin d, lin l. Oncol Rep. 2015 Mar;33(3):1481-92. doi: 10.3892/or.2015.3709. Epub 2015 Jan 8. Oncol Rep. 2015. PMID: 25571929

4

Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma.

Lin DC, Mayakonda A, Dinh HQ, Huang P, Lin L, Liu X, Ding LW, Wang J, Berman BP, Song EW, Yin D, Koeffler HP. Lin DC, et al. Among authors: lin l. Cancer Res. 2017 May 1;77(9):2255-2265. doi: 10.1158/0008-5472.CAN-16-2822. Epub 2017 Feb 20. Cancer Res. 2017. PMID: 28302680 Free PMC article.

5

LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.

Zhang Y, Huang YX, Wang DL, Yang B, Yan HY, Lin LH, Li Y, Chen J, Xie LM, Huang YS, Liao JY, Hu KS, He JH, Saw PE, Xu X, Yin D. Zhang Y, et al. Theranostics. 2020 Aug 29;10(23):10823-10837. doi: 10.7150/thno.47830. eCollection 2020. Theranostics. 2020. PMID: 32929382 Free PMC article.

6

CEBPG promotes esophageal squamous cell carcinoma progression by enhancing PI3K-AKT signaling.

Huang Y, Lin L, Shen Z, Li Y, Cao H, Peng L, Qiu Y, Cheng X, Meng M, Lu D, Yin D. Huang Y, et al. Among authors: lin l. Am J Cancer Res. 2020 Oct 1;10(10):3328-3344. eCollection 2020. Am J Cancer Res. 2020. PMID: 33163273 Free PMC article.

7

Activation of bivalent factor DLX5 cooperates with master regulator TP63 to promote squamous cell carcinoma.

Huang Y, Yang Q, Zheng Y, Lin L, Xu X, Xu XE, Silva TC, Hazawa M, Peng L, Cao H, Ding Y, Lu D, Berman BP, Xu LY, Li EM, Yin D. Huang Y, et al. Among authors: lin l. Nucleic Acids Res. 2021 Sep 20;49(16):9246-9263. doi: 10.1093/nar/gkab679. Nucleic Acids Res. 2021. PMID: 34370013 Free PMC article.

8

ARID1A and CEBPα cooperatively inhibit UCA1 transcription in breast cancer.

Guo X, Zhang Y, Mayakonda A, Madan V, Ding LW, Lin LH, Zia S, Gery S, Tyner JW, Zhou W, Yin D, Lin DC, Koeffler HP. Guo X, et al. Oncogene. 2018 Nov;37(45):5939-5951. doi: 10.1038/s41388-018-0371-4. Epub 2018 Jul 6. Oncogene. 2018. PMID: 29980791

9

Super-enhancer-associated MEIS1 promotes transcriptional dysregulation in Ewing sarcoma in co-operation with EWS-FLI1.

Lin L, Huang M, Shi X, Mayakonda A, Hu K, Jiang YY, Guo X, Chen L, Pang B, Doan N, Said JW, Xie J, Gery S, Cheng X, Lin Z, Li J, Berman BP, Yin D, Lin DC, Koeffler HP. Lin L, et al. Among authors: lin z, lin dc. Nucleic Acids Res. 2019 Feb 20;47(3):1255-1267. doi: 10.1093/nar/gky1207. Nucleic Acids Res. 2019. PMID: 30496486 Free PMC article.

10

Aberrant DNA Methylation in Esophageal Squamous Cell Carcinoma: Biological and Clinical Implications.

Lin L, Cheng X, Yin D. Lin L, et al. Front Oncol. 2020 Oct 23;10:549850. doi: 10.3389/fonc.2020.549850. eCollection 2020. Front Oncol. 2020. PMID: 33194605 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20,538 results

Search Page